YORK, Pa., Feb. 3, 2011 /PRNewswire/ — Unilife Corporation
(“Unilife” or the “Company”) (Nasdaq:
UNIS; ASX: UNS) today announced that it has appointed Dr. Ramin
Mojdeh, formerly Vice President and General Manager of Becton
Dickinson (BD) Pharmaceutical Systems, North America, and Worldwide
Vice President of Research and Development, BD Medical, as its new
Chief Operating Officer and Executive Vice President, effective
February 7, 2011.
Dr. Mojdeh comes to Unilife with more than 25 years of business
leadership experience across multiple industries, including 18
years in the design, development, manufacturing, sales and
marketing of therapeutic and diagnostic medical devices for several
multinational companies, including BD, GE Healthcare and Boston
Scientific (formerly “Guidant Corporation”). He has developed
and maintained strong relationships with many pharmaceutical
manufacturers that utilize prefilled syringes for their injectable
drugs and vaccines.
As COO, Dr. Mojdeh will lead Unilife’s operating team as the
Company prepares to enter its next phase of business expansion with
the commercial production of the Unifill® ready-to-fill
(prefilled) syringe this quarter, and its supply to pharmaceutical
customers. Dr. Mojdeh will also help to expand and accelerate
discussions with pharmaceutical companies regarding the Unifill
syringe, as well as the commercialization of a number of key
pipeline products being developed by the Company.
Dr. Mojdeh spent the last eight years working with BD, one of
the world’s leading suppliers of medical devices, including
prefilled syringes. He served as the Vice President and General
Manager of BD Medical, Pharmaceutical Systems, North America from
2008 to 2010. In this role, he directed all aspects of the North
America operations including sales, marketing, business
development, commercial development, financ
‘/>”/>
